Literature DB >> 435557

Chemical and physical properties of human bronchial mucus glycoproteins.

G Lamblin, M Lhermitte, P Degand, P Roussel, H S Slayter.   

Abstract

Human bronchial mucus glycoproteins of different chemical types were isolated by Ecteola and gel exclusion chromatography. Chemical analysis indicated polydispersity with regard to content of sulfate and sialic acid. No blood group A, B or H activity was found in these glycoproteins. Compositions are reported for amino acid and sugar residues for several fractions obtained from both cystic fibrotic and chronic bronchitic mucus. It is noteworthy that glycoproteins extracted from a single subject contain molecules with different acid groups as well as significant differences in carbohydrate chain length.

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 435557     DOI： 10.1016/s0300-9084(79)80310-7

Source DB:  PubMed          Journal:  Biochimie        ISSN： 0300-9084            Impact factor:   4.079


  11 in total

1.  Mucins secreted by a transformed cell line derived from human tracheal gland cells.

Authors:  J M Lo-Guidice; M D Merten; G Lamblin; N Porchet; M C Houvenaghel; C Figarella; P Roussel; J M Perini
Journal:  Biochem J       Date:  1997-09-01       Impact factor: 3.857

2.  Fibronectin: source of mannose in a highly purified respiratory mucin.

Authors:  S N Bhattacharyya; B Kaufman; A Khorrami; J I Enriquez; B Manna
Journal:  Inflammation       Date:  1988-10       Impact factor: 4.092

3.  Further evidence for a flexible and highly expanded spheroidal model for mucus glycoproteins in solution.

Authors:  S E Harding; A J Rowe; J M Creeth
Journal:  Biochem J       Date:  1983-03-01       Impact factor: 3.857

4.  Structure of two sulphated oligosaccharides from respiratory mucins of a patient suffering from cystic fibrosis. A fast-atom-bombardment m.s. and 1H-n.m.r. spectroscopic study.

Authors:  G Lamblin; H Rahmoune; J M Wieruszeski; M Lhermitte; G Strecker; P Roussel
Journal:  Biochem J       Date:  1991-04-01       Impact factor: 3.857

5.  The macromolecular structure of human cervical-mucus glycoproteins. Studies on fragments obtained after reduction of disulphide bridges and after subsequent trypsin digestion.

Authors:  I Carlstedt; H Lindgren; J K Sheehan
Journal:  Biochem J       Date:  1983-08-01       Impact factor: 3.857

6.  Arylneuraminidase activity of Pseudomonas aeruginosa does not degrade natural substrates such as human respiratory mucins.

Authors:  A Scharfman; R Ramphal; C Neut; C Carnoy; G Lamblin; P Roussel
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

7.  Interaction between secretory leucocyte proteinase inhibitor and bronchial mucins or glycopeptides. Physiopathological implications for the protection of mucins against proteolysis by human leucocyte elastase.

Authors:  I Van-Seuningen; J P Aubert; M Davril
Journal:  Biochem J       Date:  1992-02-01       Impact factor: 3.857

8.  Differences in adhesion of Pseudomonas aeruginosa to mucin glycopeptides from sputa of patients with cystic fibrosis and chronic bronchitis.

Authors:  R Ramphal; N Houdret; L Koo; G Lamblin; P Roussel
Journal:  Infect Immun       Date:  1989-10       Impact factor: 3.441

9.  Deglycosylation of neutral and acidic human colonic mucin.

Authors:  S N Bhattacharyya; J I Enriquez; B Manna
Journal:  Inflammation       Date:  1990-02       Impact factor: 4.092

10.  Structural features of human tracheobronchial mucus glycoprotein.

Authors:  M C Rose; W A Voter; C F Brown; B Kaufman
Journal:  Biochem J       Date:  1984-09-01       Impact factor: 3.857
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.